FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W4304187878> ?p ?o ?g. }

• W4304187878 abstract "Abstract Background Carbapenem-resistant Enterobacterales (CRE) is an urgent public health threat of significant global concern. Few observational studies have evaluated the clinical outcomes for treatment of CRE harbouring OXA-48 or NDM genes with ceftazidime/avibactam. Previous findings showed lower 30 day mortality with ceftazidime/avibactam ranges between 8.3% and 22%. Method This single-centre retrospective cohort study included adult patients aged ≥18 years admitted to King Abdulaziz Medical City (KAMC) who had received ceftazidime/avibactam for at least 72 h for infections caused by CRE with genes encoding for carbapenemase production (CP-CRE). Results A total of 211 patients, mostly male (57%), having CP-CRE infections treated with ceftazidime/avibactam were included, with an average age of 62 years. More than 50% of patients were critically ill, for which 46% received invasive ventilation and 36% were on inotropes. The most frequent infectious disease was hospital/ventilator-acquired pneumonia with Klebsiella pneumoniae being the most frequent causative pathogen. The majority of isolates harboured OXA-48 (81%), followed by NDM ± OXA-48 (19%). The overall clinical cure and 30 day mortality was 78% and 21% respectively (stratified per gene: 79% and 21.6% for OXA-48 and 75% and 17.5% for NDM ± OXA-48). Conclusions This was the largest study that evaluated clinical outcomes associate with CP-CRE harbouring OXA-48 gene infections treated with ceftazidime/avibactam. Clinical cure and 30 day mortality were consistent with those of previous studies. Findings suggested that combination therapy with ceftazidime/avibactam had no direct impact on clinical outcomes for CP-CRE with OXA-48." @default.
• W4304187878 created "2022-10-11" @default.
• W4304187878 creator A5005255296 @default.
• W4304187878 creator A5012914549 @default.
• W4304187878 creator A5013053495 @default.
• W4304187878 creator A5016301179 @default.
• W4304187878 creator A5018330002 @default.
• W4304187878 creator A5020436137 @default.
• W4304187878 creator A5028543712 @default.
• W4304187878 creator A5037382701 @default.
• W4304187878 creator A5061385772 @default.
• W4304187878 creator A5088628393 @default.
• W4304187878 creator A5091834476 @default.
• W4304187878 date "2022-09-05" @default.
• W4304187878 modified "2023-10-14" @default.
• W4304187878 title "Evaluation of ceftazidime/avibactam for treatment of carbapenemase-producing carbapenem-resistant Enterobacterales with OXA-48 and/or NDM genes with or without combination therapy" @default.
• W4304187878 cites W2095542161 @default.
• W4304187878 cites W2497057717 @default.
• W4304187878 cites W2513238037 @default.
• W4304187878 cites W2886143224 @default.
• W4304187878 cites W2901851195 @default.
• W4304187878 cites W2909817794 @default.
• W4304187878 cites W2971663956 @default.
• W4304187878 cites W3026777707 @default.
• W4304187878 cites W3040595104 @default.
• W4304187878 cites W3044749399 @default.
• W4304187878 cites W3148623141 @default.
• W4304187878 cites W3152277767 @default.
• W4304187878 cites W3169832973 @default.
• W4304187878 cites W4226129064 @default.
• W4304187878 doi "https://doi.org/10.1093/jacamr/dlac104" @default.
• W4304187878 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/36237571" @default.
• W4304187878 hasPublicationYear "2022" @default.
• W4304187878 type Work @default.
• W4304187878 citedByCount "2" @default.
• W4304187878 countsByYear W43041878782023 @default.
• W4304187878 crossrefType "journal-article" @default.
• W4304187878 hasAuthorship W4304187878A5005255296 @default.
• W4304187878 hasAuthorship W4304187878A5012914549 @default.
• W4304187878 hasAuthorship W4304187878A5013053495 @default.
• W4304187878 hasAuthorship W4304187878A5016301179 @default.
• W4304187878 hasAuthorship W4304187878A5018330002 @default.
• W4304187878 hasAuthorship W4304187878A5020436137 @default.
• W4304187878 hasAuthorship W4304187878A5028543712 @default.
• W4304187878 hasAuthorship W4304187878A5037382701 @default.
• W4304187878 hasAuthorship W4304187878A5061385772 @default.
• W4304187878 hasAuthorship W4304187878A5088628393 @default.
• W4304187878 hasAuthorship W4304187878A5091834476 @default.
• W4304187878 hasBestOaLocation W43041878781 @default.
• W4304187878 hasConcept C104317684 @default.
• W4304187878 hasConcept C126322002 @default.
• W4304187878 hasConcept C167135981 @default.
• W4304187878 hasConcept C177713679 @default.
• W4304187878 hasConcept C2775933652 @default.
• W4304187878 hasConcept C2776685102 @default.
• W4304187878 hasConcept C2776968632 @default.
• W4304187878 hasConcept C2777058267 @default.
• W4304187878 hasConcept C2777406300 @default.
• W4304187878 hasConcept C2777637488 @default.
• W4304187878 hasConcept C501593827 @default.
• W4304187878 hasConcept C523546767 @default.
• W4304187878 hasConcept C54355233 @default.
• W4304187878 hasConcept C547475151 @default.
• W4304187878 hasConcept C55493867 @default.
• W4304187878 hasConcept C71924100 @default.
• W4304187878 hasConcept C86803240 @default.
• W4304187878 hasConcept C89423630 @default.
• W4304187878 hasConceptScore W4304187878C104317684 @default.
• W4304187878 hasConceptScore W4304187878C126322002 @default.
• W4304187878 hasConceptScore W4304187878C167135981 @default.
• W4304187878 hasConceptScore W4304187878C177713679 @default.
• W4304187878 hasConceptScore W4304187878C2775933652 @default.
• W4304187878 hasConceptScore W4304187878C2776685102 @default.
• W4304187878 hasConceptScore W4304187878C2776968632 @default.
• W4304187878 hasConceptScore W4304187878C2777058267 @default.
• W4304187878 hasConceptScore W4304187878C2777406300 @default.
• W4304187878 hasConceptScore W4304187878C2777637488 @default.
• W4304187878 hasConceptScore W4304187878C501593827 @default.
• W4304187878 hasConceptScore W4304187878C523546767 @default.
• W4304187878 hasConceptScore W4304187878C54355233 @default.
• W4304187878 hasConceptScore W4304187878C547475151 @default.
• W4304187878 hasConceptScore W4304187878C55493867 @default.
• W4304187878 hasConceptScore W4304187878C71924100 @default.
• W4304187878 hasConceptScore W4304187878C86803240 @default.
• W4304187878 hasConceptScore W4304187878C89423630 @default.
• W4304187878 hasIssue "5" @default.
• W4304187878 hasLocation W43041878781 @default.
• W4304187878 hasLocation W43041878782 @default.
• W4304187878 hasLocation W43041878783 @default.
• W4304187878 hasOpenAccess W4304187878 @default.
• W4304187878 hasPrimaryLocation W43041878781 @default.
• W4304187878 hasRelatedWork W1787970496 @default.
• W4304187878 hasRelatedWork W2565726837 @default.
• W4304187878 hasRelatedWork W2794121289 @default.
• W4304187878 hasRelatedWork W2901057130 @default.
• W4304187878 hasRelatedWork W2982773974 @default.
• W4304187878 hasRelatedWork W3081203806 @default.
• W4304187878 hasRelatedWork W3111122494 @default.
• W4304187878 hasRelatedWork W3182797719 @default.
• W4304187878 hasRelatedWork W4360587546 @default.

• next